Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
35.15
0.00 (0.00%)
Nov 20, 2025, 4:00 PM EST
Genus Market Cap
Genus has a market cap or net worth of $2.2 billion as of November 21, 2025. Its market cap has increased by 34.54% in one year.
Market Cap
2.20B
Enterprise Value
2.49B
Revenue
921.77M
Ranking
n/a
PE Ratio
83.32
Stock Price
$35.15
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 50.66M to 2.20B, an increase of 4,248.96%. That is a compound annual growth rate of 14.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 2.26B | 77.43% |
| Dec 31, 2024 | 1.27B | -29.66% |
| Dec 29, 2023 | 1.81B | -22.93% |
| Dec 30, 2022 | 2.35B | -46.03% |
| Dec 31, 2021 | 4.36B | 17.14% |
| Dec 31, 2020 | 3.72B | 36.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.30M |
| Elite Pharmaceuticals | 624.11M |
| Glass House Brands | 451.06M |
| CytoDyn | 396.27M |
| American Oncology Network | 369.77M |
| Northwest Biotherapeutics | 355.00M |
| Silence Therapeutics | 316.47M |
| Nika Pharmaceuticals | 311.89M |